Human growth hormone therapy in children with growth hormone deficiency
Conference paper
Abstract
The growth-promoting effect of human growth hormone (hGH) in children with classical pituitary GH deficiency is widely accepted (Frasier 1983). However, it is sometimes difficult to diagnose whether a child has enough endogenous GH secretion or not. Once the safety and efficacy of recombinant hGH (r-hGH) were established, it became possible to use r-hGH for the treatment of short statured children other than just those with classical pituitary GH deficiency (Spiliotis et al. 1984; Stahnke 1984).
Keywords
Growth Hormone Growth Hormone Deficiency Human Growth Hormone Plasma Growth Hormone Growth Hormone Concentration
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- Albertsson-Wikland K (1987) Clinical trial with authentic recombinant somatropin in Sweden and Finland. Acta Paediatr Scand[Suppl] 331: 28–37CrossRefGoogle Scholar
- Bereu BB, Shulman D, Root AW, Spiliotis BE (1986) Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab 63:709–714CrossRefGoogle Scholar
- Frasier SD (1983) Human pituitary growth hormone (hGH) therapy in growth hormone deficiency. Endocr Rev 4: 155–170PubMedCrossRefGoogle Scholar
- Hashida S, Ishikawa E, Nakagawa K, Ohtaki S, Ichioka T, Nakajima K (1985) Demonstration of human growth hormone in normal urine by a highly specific and sensitive sandwich enzyme immunoassay. Anal Lett 18: 1623CrossRefGoogle Scholar
- Kaplan SL, Underwood LE, August GP, Bell JJ, Blethen SL, Blizzard RM, et al. (1986) Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone-deficient children. Lancet i: 697–700CrossRefGoogle Scholar
- Ross JL, Long LM, Loriaux LD, Cutler GB Jr (1985) Growth hormone secretory dynamics in Turner’s syndrome. J Pediatr 106:202–206PubMedCrossRefGoogle Scholar
- Stahnke N (1984) Human growth hormone treatment in short children without growth hormone deficiency. New Engl J Med 310:925–926PubMedCrossRefGoogle Scholar
- Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bereu BB (1984) Growth hormone neurosecretory dysfunction. A tretable cause of short stature. JAMA 251:2223–2230PubMedCrossRefGoogle Scholar
- Sukegawa I, Hizuka N, Takano K, Asakawa K, Horikawa R, Ishikawa E, Mohri Z, Murakami Y, Shizume K (1988) Measurement of urinary growth hormone (GH) values is useful for evaluating endogenous GH secretion. J Clin Endocrinol Metab 66:1119–1123PubMedCrossRefGoogle Scholar
- Takano K, Hizuka N, Shizume K (1986a) Treatment of Turner’s syndrome with methionyl human growth hormone for six months. Acta Endocrinol (Copenh) 112:130–137Google Scholar
- Takano K, Shizume K, Hizuka N, Okuno A, Umino T, Kobayashi Y, et al. (1986b) Treatment of pituitary dwarfism with methionyl human growth hormone in Japan. Endocrinol Jpn 33:589–596PubMedCrossRefGoogle Scholar
- Takano K, Shizume K, Hibi I, Okuno A, Hanyu K, Suwa S, et al. (1987) Treatment of pituitary dwarfism with authentic recombinant human growth hormone (SM-9500). Endocrinol Jpn 34: 291–297PubMedCrossRefGoogle Scholar
- Villadolid MC, Takano K, Hizuka N, Asakawa K, Sukegawa I, Horikawa R, Shizume K (1988) Twenty-four-hour plasma GH, FSH and LH profiles in patients with Turner’s syndrome. Endocrinol Jpn 35: 71–81PubMedCrossRefGoogle Scholar
- Zadik Z, Chalew SA, Raiti S, Kowarski AA (1985) Do short children secrete insufficient quantities of growth hormone? Pediatrics 76: 355–360PubMedGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 1989